Growing with the power of ‘Wan’

Wan Amir-Jeffrey: My job is to preserve what defines us while empowering our people to think ahead and lead Duopharma Biotech into its next chapter.

WAN Amir-Jeffrey Wan Abdul Majid did not waste time getting into his new role as Duopharma Biotech Bhd’s group chief executive officer (CEO). Taking over from long-serving group managing director Leonard Ariff Abdul Shatar effective Oct 1, he gave his first media interview as the new head of Malaysia’s leading homegrown pharmaceutical company – outlining a strategy built on continuity, discipline, and renewed energy for growth.

“My appointment represents continuity in Duopharma Biotech’s leadership journey,” he says. “It reinforces stakeholder confidence and reflects the maturity of our succession planning process and the depth of talent we’ve built internally.”